Executive Summary
Meta Platforms petitions the PTAB to invalidate all 16 claims of SitNet’s ’345 patent, arguing they are obvious over Gage, Mitchell, Shida, and Sinha. The petition emphasizes strong discretionary factors favoring institution.
Related Cases
Sun Pharmaceutical Industries, Inc.vsNivagen Pharmaceuticals, Inc.
Sun Pharmaceutical has filed a request for Director Review after the PTAB denied institution of its IPR challenging Nivagen’s orphan‑drug patent. The petitioner argues the denial improperly treated claim‑construction issues as discretionary and was issued by the wrong official.
Samsung Electronics Co. Ltd. et al.vsMaxell, LTD.
Samsung Electronics filed an IPR petition seeking cancellation of claims 1‑4 of Maxell’s U.S. Patent 11,277,650. The petition argues the claims are obvious over three prior‑art references—Shindo, Sasaki, and a combination of Futa and McClellan—under 35 U.S.C. §103. The petition requests that all challenged claims be found unpatentable.
MediaTek Inc.vsDAEDALUS PRIME LLC
MediaTek and Daedalus Prime have settled their IPR dispute and filed a joint motion to have the settlement agreement treated as business confidential information under 35 USC 317(b). The Board is asked to keep the agreement separate from the patent file and limit access.
Abbott LaboratoriesvsNewtonoid Technologies, LLC
Abbott Laboratories challenged Newtonoid Technologies' '818 patent, asserting obviousness over prior art references like Prusik and Vaillant. The PTAB issued an institution decision finding a reasonable likelihood of prevailing on all 20 challenged claims.
IKEA Supply AG et al.vsEverlight Electronics Co., Ltd.
IKEA Supply AG successfully convinced the PTAB to institute an IPR against Everlight Electronics Co., Ltd.'s patent 9640733. The Board found a reasonable likelihood of success on multiple grounds, including anticipation and obviousness based on prior art references like Kishikawa and Nakashima. This sets the stage for a full trial focusing on LED packaging technology.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.